Linda A. Parker
- Published in print:
- 2017
- Published Online:
- September 2017
- ISBN:
- 9780262035798
- eISBN:
- 9780262338448
- Item type:
- book
- Publisher:
- The MIT Press
- DOI:
- 10.7551/mitpress/9780262035798.001.0001
- Subject:
- Neuroscience, Research and Theory
Cannabinoids and the Brain introduces an informed general audience to the scientific discovery of the endocannabinoid system and recent preclinical research that explains its importance in brain ...
More
Cannabinoids and the Brain introduces an informed general audience to the scientific discovery of the endocannabinoid system and recent preclinical research that explains its importance in brain functioning. The endocannabinoids, anandamide and 2-AG, act on the same cannabinoid receptors, that are activated by the primary psychoactive compound found in marijuana, Δ9-tetrahydrocannabinol (THC). Therefore, the scientific investigations of the functions of the endocannabinoid system are guided by the known effects of marijuana on the brain and body. The book reviews the scientific evidence of the role that the endocannabinoid system plays in regulating emotion, anxiety, depression, psychosis, reward and addiction, learning and memory, feeding, nausea/vomiting, pain, epilepsy, and other neurological disorders. Anecdotal reports are linked with the current scientific literature on the medicinal benefits of marijuana. Cannabis contains over 80 chemicals that have closely related structures, called cannabinoids, but the only major mood-altering constituent is THC. Another major plant cannabinoid is cannabidiol (CBD), which is not psychoactive; yet, considerable recent preclinical research reviewed in various chapters reveals that CBD has promising therapeutic potential in treatment of pain, anxiety, nausea and epilepsy. Only recently, has research been conducted with some of the other compounds found in cannabis. The subject matter of the book is extremely timely in light of the current ongoing debate not only about medical marijuana, but also about its legal status.Less
Cannabinoids and the Brain introduces an informed general audience to the scientific discovery of the endocannabinoid system and recent preclinical research that explains its importance in brain functioning. The endocannabinoids, anandamide and 2-AG, act on the same cannabinoid receptors, that are activated by the primary psychoactive compound found in marijuana, Δ9-tetrahydrocannabinol (THC). Therefore, the scientific investigations of the functions of the endocannabinoid system are guided by the known effects of marijuana on the brain and body. The book reviews the scientific evidence of the role that the endocannabinoid system plays in regulating emotion, anxiety, depression, psychosis, reward and addiction, learning and memory, feeding, nausea/vomiting, pain, epilepsy, and other neurological disorders. Anecdotal reports are linked with the current scientific literature on the medicinal benefits of marijuana. Cannabis contains over 80 chemicals that have closely related structures, called cannabinoids, but the only major mood-altering constituent is THC. Another major plant cannabinoid is cannabidiol (CBD), which is not psychoactive; yet, considerable recent preclinical research reviewed in various chapters reveals that CBD has promising therapeutic potential in treatment of pain, anxiety, nausea and epilepsy. Only recently, has research been conducted with some of the other compounds found in cannabis. The subject matter of the book is extremely timely in light of the current ongoing debate not only about medical marijuana, but also about its legal status.
Linda A. Parker
- Published in print:
- 2017
- Published Online:
- September 2017
- ISBN:
- 9780262035798
- eISBN:
- 9780262338448
- Item type:
- chapter
- Publisher:
- The MIT Press
- DOI:
- 10.7551/mitpress/9780262035798.003.0001
- Subject:
- Neuroscience, Research and Theory
Although cannabis has been used throughout human history, the scientific investigation of its effects only began with the isolation of THC in the 1960’s. Once discovered it was another 20 years ...
More
Although cannabis has been used throughout human history, the scientific investigation of its effects only began with the isolation of THC in the 1960’s. Once discovered it was another 20 years before the mechanism by which THC produces its psychoactive effects in the brain, the CB1 receptor, was discovered. Cannabis contains over 80 cannabinoid compounds, but THC is the only intoxicating compound. Recent preclinical research is being directed towards evaluating the therapeutic potential of other cannabinoid compounds found in cannabis, including CBD. The pharmacokinetics of THC, methods of administration, and dosing issues are explored in Chapter 1.Less
Although cannabis has been used throughout human history, the scientific investigation of its effects only began with the isolation of THC in the 1960’s. Once discovered it was another 20 years before the mechanism by which THC produces its psychoactive effects in the brain, the CB1 receptor, was discovered. Cannabis contains over 80 cannabinoid compounds, but THC is the only intoxicating compound. Recent preclinical research is being directed towards evaluating the therapeutic potential of other cannabinoid compounds found in cannabis, including CBD. The pharmacokinetics of THC, methods of administration, and dosing issues are explored in Chapter 1.